FLORINEF DIN 02086026
Status: Marketed
Holder: KNIGHT THERAPEUTICS INC.
Molecule: FLUDROCORTISONE 21-ACETATE
Available to quote
Health Canada record
| Active ingredient(s) | FLUDROCORTISONE 21-ACETATE 0.1 MG |
|---|---|
| Dosage form | Tablet |
| Route | Oral |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | H02AA02 FLUDROCORTISONE |
| Original market date | 31-Dec-1995 |
| Current status date | 24-Mar-2026 |
| Source | Health Canada DPD |
Establishment licence of the holder
Knight Therapeutics Inc. — licence 3-002350, currently licensed, last inspection rating C (2025-11-05).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing FLUDROCORTISONE 21-ACETATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02552248 | JAMP FLUDROCORTISONE | JAMP PHARMA CORPORATION | Tablet | FLUDROCORTISONE 21-ACETATE 0.1 MG | Marketed |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 37171 | 2026-03-24 | New Drug Submission (NDS) | Administrative: Change in product ownership |
| 10214 | 2009-05-15 | New Drug Submission (NDS) | Manufacturer name change |
| 8781 | 2007-05-14 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |